Quality of life, control of treatment and satisfaction of patients with asthma in Bulgaria: a pilot study
Authors
Doneva, MiglenaMilushewa, Petya
Dimitrova, Maria
Kamusheva, Maria

Stoitchkov, Jordan
Petrova, Guenka

Naydenova, Kremena
Krusheva, Borislava
Dimitrov, Vasil
Lakić, Dragana

Article (Published version)
Metadata
Show full item recordAbstract
This study aims to evaluate clinical characteristics, quality of life and control of treatment and therapy satisfaction of patients with asthma in Bulgaria. A pilot study of Bulgarian patients with asthma selected by allergologists was performed. The predefined inclusion criteria were asthma diagnosis with at least 6 months of living with asthma and use of asthma medication. Patient characteristics, treatment, quality-of-life, control of asthma and therapy satisfaction were systematically assessed. A retrospective observational study was conducted among asthma patients in Sofia in 2019. A strict definition of asthma-based solely on physicians’ diagnosis was used. Allergologists from two national reference hospitals for asthma therapy selected asthma patients. Every third patient with asthma that visited the office within 5 months period, and that agreed to participate was selected for the study. Quality-of-life of patients was measured using the EQ5D Assessment Test, control of asthma ...was assessed using ATCQ and ATC tests. A total of 71 asthma patients were enrolled. Approximately 43.6% were male, 16.9% were smokers, occupational risk factors were low (4.22%), 25% had moderate and 38% had severe asthma. The mean scores of asthma control treatment were 16.92 ± 5.68. The group has relatively high percentages of severe asthma patients. The asthma was not well controlled. National asthma strategies should focus on prevention and early detection of the disease.
Keywords:
Asthma control / quality of life of patients / satisfaction of treatmentSource:
Biotechnology and Biotechnological Equipment, 2022, 36, 1, 478-485Publisher:
- Taylor and Francis Ltd.
DOI: 10.1080/13102818.2022.2098818
ISSN: 1310-2818
WoS: 000827990700001
Scopus: 2-s2.0-85134371309
Collections
Institution/Community
PharmacyTY - JOUR AU - Doneva, Miglena AU - Milushewa, Petya AU - Dimitrova, Maria AU - Kamusheva, Maria AU - Stoitchkov, Jordan AU - Petrova, Guenka AU - Naydenova, Kremena AU - Krusheva, Borislava AU - Dimitrov, Vasil AU - Lakić, Dragana PY - 2022 UR - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4202 AB - This study aims to evaluate clinical characteristics, quality of life and control of treatment and therapy satisfaction of patients with asthma in Bulgaria. A pilot study of Bulgarian patients with asthma selected by allergologists was performed. The predefined inclusion criteria were asthma diagnosis with at least 6 months of living with asthma and use of asthma medication. Patient characteristics, treatment, quality-of-life, control of asthma and therapy satisfaction were systematically assessed. A retrospective observational study was conducted among asthma patients in Sofia in 2019. A strict definition of asthma-based solely on physicians’ diagnosis was used. Allergologists from two national reference hospitals for asthma therapy selected asthma patients. Every third patient with asthma that visited the office within 5 months period, and that agreed to participate was selected for the study. Quality-of-life of patients was measured using the EQ5D Assessment Test, control of asthma was assessed using ATCQ and ATC tests. A total of 71 asthma patients were enrolled. Approximately 43.6% were male, 16.9% were smokers, occupational risk factors were low (4.22%), 25% had moderate and 38% had severe asthma. The mean scores of asthma control treatment were 16.92 ± 5.68. The group has relatively high percentages of severe asthma patients. The asthma was not well controlled. National asthma strategies should focus on prevention and early detection of the disease. PB - Taylor and Francis Ltd. T2 - Biotechnology and Biotechnological Equipment T1 - Quality of life, control of treatment and satisfaction of patients with asthma in Bulgaria: a pilot study VL - 36 IS - 1 SP - 478 EP - 485 DO - 10.1080/13102818.2022.2098818 ER -
@article{ author = "Doneva, Miglena and Milushewa, Petya and Dimitrova, Maria and Kamusheva, Maria and Stoitchkov, Jordan and Petrova, Guenka and Naydenova, Kremena and Krusheva, Borislava and Dimitrov, Vasil and Lakić, Dragana", year = "2022", abstract = "This study aims to evaluate clinical characteristics, quality of life and control of treatment and therapy satisfaction of patients with asthma in Bulgaria. A pilot study of Bulgarian patients with asthma selected by allergologists was performed. The predefined inclusion criteria were asthma diagnosis with at least 6 months of living with asthma and use of asthma medication. Patient characteristics, treatment, quality-of-life, control of asthma and therapy satisfaction were systematically assessed. A retrospective observational study was conducted among asthma patients in Sofia in 2019. A strict definition of asthma-based solely on physicians’ diagnosis was used. Allergologists from two national reference hospitals for asthma therapy selected asthma patients. Every third patient with asthma that visited the office within 5 months period, and that agreed to participate was selected for the study. Quality-of-life of patients was measured using the EQ5D Assessment Test, control of asthma was assessed using ATCQ and ATC tests. A total of 71 asthma patients were enrolled. Approximately 43.6% were male, 16.9% were smokers, occupational risk factors were low (4.22%), 25% had moderate and 38% had severe asthma. The mean scores of asthma control treatment were 16.92 ± 5.68. The group has relatively high percentages of severe asthma patients. The asthma was not well controlled. National asthma strategies should focus on prevention and early detection of the disease.", publisher = "Taylor and Francis Ltd.", journal = "Biotechnology and Biotechnological Equipment", title = "Quality of life, control of treatment and satisfaction of patients with asthma in Bulgaria: a pilot study", volume = "36", number = "1", pages = "478-485", doi = "10.1080/13102818.2022.2098818" }
Doneva, M., Milushewa, P., Dimitrova, M., Kamusheva, M., Stoitchkov, J., Petrova, G., Naydenova, K., Krusheva, B., Dimitrov, V.,& Lakić, D.. (2022). Quality of life, control of treatment and satisfaction of patients with asthma in Bulgaria: a pilot study. in Biotechnology and Biotechnological Equipment Taylor and Francis Ltd.., 36(1), 478-485. https://doi.org/10.1080/13102818.2022.2098818
Doneva M, Milushewa P, Dimitrova M, Kamusheva M, Stoitchkov J, Petrova G, Naydenova K, Krusheva B, Dimitrov V, Lakić D. Quality of life, control of treatment and satisfaction of patients with asthma in Bulgaria: a pilot study. in Biotechnology and Biotechnological Equipment. 2022;36(1):478-485. doi:10.1080/13102818.2022.2098818 .
Doneva, Miglena, Milushewa, Petya, Dimitrova, Maria, Kamusheva, Maria, Stoitchkov, Jordan, Petrova, Guenka, Naydenova, Kremena, Krusheva, Borislava, Dimitrov, Vasil, Lakić, Dragana, "Quality of life, control of treatment and satisfaction of patients with asthma in Bulgaria: a pilot study" in Biotechnology and Biotechnological Equipment, 36, no. 1 (2022):478-485, https://doi.org/10.1080/13102818.2022.2098818 . .